Results 21 to 30 of about 7,222 (160)

A RCT of a third dose CoronaVac or BNT162b2 vaccine in adults with two doses of CoronaVac [PDF]

, 2021
Abstract Background Poor immunogenicity and antibody waning were found in vaccinees of CoronaVac. There is lack of randomized controlled trial (RCT) data to compare the immunogenicity and safety of schedules using homologous and heterologous vaccine as a booster dose.
Chris Ka Pun Mok, Samuel M.S. Cheng, Chunke Chen, Karen Yiu, Tat-On Chan, Kiu Cheung Lai, Kwun Cheung Ling, Yuanxin Sun, Lun Lai Ho, Malik Peiris, David S Hui   +10 more
openaire   +1 more source

Effect of Pfizer/BioNTech and Sinovac/CoronaVac Vaccines on Semen Parameters in Infertile Patients with Idiopathic Infertility: A Single-center Cohort Study [PDF]

, 2023
Objective:We investigated the effects of Coronavirus disease-2019 (COVID-19) vaccines on semen parameters in patients with idiopathic infertility who visited our urology clinic.Materials and Methods:Patients who visited our andrology clinic between ...
Dil, Eyüp, Eyüp Dil
core   +1 more source

Immunoglobulin G and neutralizing antibody response after CoronaVac. [PDF]

Rev Assoc Med Bras (1992)
SUMMARY OBJECTIVE: The aim of this study was to evaluate the kinetics of immunoglobulin G and neutralizing antibody responses following vaccination with CoronaVac in healthcare professionals. METHODS: A cohort of 35 healthcare professionals was recruited, and blood samples were collected to assess immunoglobulin G detection and neutralizing ...
Assis PBC, Ferreira LN, Magalhães FMV, Távora PF, Santos LID.   +4 more
europepmc   +4 more sources

Humoral Immune Response of BNT162b2 and CoronaVac Vaccinations in Hemodialysis Patients: A Multicenter Prospective Cohort [PDF]

, 2022
The CoronaVac vaccine is the most used anti-SARS-CoV-2 vaccine worldwide. Previous data indicate that this vaccine produces a lower immune response than RNA vaccines such as BNT162b2.
Gajardo, Cynthia, Méndez Valdés, Gabriel Andrés, Angelica Ordenes, Toro, Luis, Josseline Aranda, Villa, Eduardo, Parra-Lucares, Alfredo, Zúñiga, José, Ordenes, Angelica, Toro Cabrera, Luis Alejandro, Luis Toro, Evelyn Mondaca, Jessica Tapia, Parra Lucares, Alfredo Andrés, Bravo, Karin, Karin Bravo, Tapia, Jessica, Andoni Etcheverry, José Zúñiga, Gabriel Méndez-Valdés, Brignardello, Rose, Evelyn Colombo, Alfredo Parra-Lucares, Aranda, Josseline, Rose Brignardello, Clavero, Rene, Bravo Espinoza, Karin Constanza, Mondaca, Evelyn, Eduardo Villa, Colombo, Evelyn, Etcheverry, Andoni, Cynthia Gajardo, Rene Clavero, Méndez-Valdés, Gabriel   +33 more
core   +1 more source

ANCA-associated vasculitis following the CoronaVac vaccination

Therapeutic Advances in Chronic Disease, 2022
With the coronavirus disease 2019 (COVID-19) pandemic, vaccination has become one of the cornerstones to contain the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Large clinical trials have shown high efficacy and safety of SARS-CoV-2 vaccination against COVID-19.
Yaohui Ma, Tianlun Huang, Gaosi Xu
openaire   +3 more sources

CoronaVac Chile

, 2021
Dataset of tweets about CoronaVac in ...
Patricio Ramírez-Correa (11387177)
core   +1 more source

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine [PDF]

, 2022
OBJECTIVE: Despite the high vaccine efficacy of mRNA COVID‐19 vaccines, there are individuals who developed excessive reactogenic and/or allergic responses after the first mRNA dose and were considered ineligible for further mRNA doses.
Jean‐Marc Chavatte, Matthew Zirui Tay, Zi Wei Chang, Poh Lian Lim, Surinder Pada, Chavatte, JM, Fong, Siew-Wai, Yong Jie Tan, Pei Xiang Hor, Raymond TP Lin, Loh, CY, Zhuo, NZ, Tan, Yong Jie, Ong, DLS, Ngoh, EZX, Yee‐Sin Leo, Salleh, Siti Nazihah Mohd, Pada, Surinder, Somani, J, Ren, EC, Tay, Matthew Zirui, Renia, L, Siew‐Wai Fong, Lye, DC, Eng Sing Lee, Lye, David C, Angeline Rouers, Barnaby Edward Young, Rouers, A, Fong, Siew‐Wai, Wang, B, Wang, CI, Young, Barnaby Edward, Joel Xu En Wong, Raphael Tze Chuen Lee, Zhuo, Nicole Ziyi, Lee, ES, Chiew Yee Loh, Tay, MZ, Lee, RTC, Bei Wang, Leo, YS, Wang, Cheng‐I, Daniel Rui Xiang Lim, Goh, Yun Shan, Sun, LJ, Renia, Laurent, Chang, ZW, Pada, S, Lim, PL, Laurent Renia, Chavatte, Jean-Marc, Loh, Chiew Yee, Maurer-Stroh, S, Chang, Zi Wei, Lim, Daniel Rui Xiang, Ngoh, Eve Zi Xian, Ng, LFP, Rouers, Angeline, Wang, Bei, Chavatte, Jean‐Marc, Sun, Louisa Jin, Jyoti Somani, Ng, Lisa FP, Lee, Eng Sing, Yuling Huang, Wong, Joel Xu En, Hor, PX, Wong, JXE, Sebastian Maurer‐Stroh, Maurer‐Stroh, Sebastian, Tan, YJ, Young, BE, Leo, Yee-Sin, Ee Chee Ren, Siti Nazihah Mohd Salleh, Desmond Luan Seng Ong, Yun Shan Goh, Somani, Jyoti, Lin, Raymond TP, Salleh, SNM, Eve Zi Xian Ngoh, Lee, Raphael Tze Chuen, Ren, Ee Chee, Maurer-Stroh, Sebastian, Nicole Ziyi Zhuo, Fong, SW, Lim, Poh Lian, Lim, DRX, Lisa FP Ng, Ong, Desmond Luan Seng, Huang, Y, Hor, Pei Xiang, David C Lye, Louisa Jin Sun, Lin, RTP, Wang, Cheng-I, Huang, Yuling, Leo, Yee‐Sin, Cheng‐I Wang, Goh, YS   +100 more
core   +1 more source

Tweets of CoronaVac in Chile

, 2021
Tweets of CoronaVac in Chile from 2020 to ...
Patricio Ramírez-Correa (11387177)
core   +1 more source

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

, 2022
Mass vaccination with a safe and effective vaccine may be the best way to control the COVID-19 pandemic. Heterologous prime-boost vaccination with the CoronaVac and AZD1222 vaccines may increase the immunogenicity elicited by either vaccine alone.
Pawornrath Jungsomsri, Kriangkrai Tawinprai, Nawarat Thonwirak, Guy Cohen, Wittayasak, Kasiruck, Gaidganok Sornsamdang, Siripongboonsitti, Taweegrit, Kasiruck Wittayasak, Jungsomsri, Pawornrath, Tawinprai, Kriangkrai, Soonklang, Kamonwan, Auewarakul, Chirayu, Kamonwan Soonklang, Mahanonda, Nithi, Porntharukchareon, Thachanun, Chirayu Auewarakul, Taweegrit Siripongboonsitti, Cohen, Guy, Nithi Mahanonda, Jirath Sangwongwanich, Sornsamdang, Gaidganok, Thachanun Porntharukchareon, Sangwongwanich, Jirath, Thonwirak, Nawarat   +23 more
core   +1 more source

Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19

Acta Pharmaceutica, 2023
Abstract This retrospective observational study is aimed to determine the efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac (Sinovac) vaccines against symptomatic or severe disease in COVID-19-diagnosed patients.
Mustafa Dogan, Berna Yilmaz
openaire   +3 more sources